BDBM370077 US10233187, Example 15::US10233187, Example 16

SMILES CC(C)OC(=O)C1=CN(CC(C)(C)c2c1[nH]nc2C(F)(F)F)C(=O)c1ccc(F)cc1F

InChI Key InChIKey=CRDQIXVDWOEIOZ-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 370077   

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandPNGBDBM370077(US10233187, Example 16 | US10233187, Example 15)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent

TargetBile acid receptor(Human)
Akarna Therapeutics

US Patent
LigandPNGBDBM370077(US10233187, Example 16 | US10233187, Example 15)
Affinity DataEC50: <200nMAssay Description:Starting from 3.33 mM of compound in DMSO solution, a 10-point 3-fold serial dilution was made by diluting 5 μL of compound into 10 μL of D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
Go to US Patent